Skba Capital Management LLC Abb Vie Inc. Transaction History

Skba Capital Management LLC

$642 Million
Q3 2024

A detailed history of Skba Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Skba Capital Management LLC holds 5,519 shares of ABBV stock, worth $910,579. This represents 0.17% of its overall portfolio holdings.

Number of Shares

5,519

Previous 5,569 0.9%

Holding current value

$910,579

Previous $955,000 14.03%

% of portfolio

0.17%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $8,192 - $9,966	-50 Reduced 0.9%	5,519 $1.09 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $54,950 - $64,169	-355 Reduced 5.99%	5,569 $955,000
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $4.18 Million - $4.71 Million	-30,400 Reduced 83.69%	5,924 $918,000
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $678,318 - $844,123	-5,119 Reduced 12.35%	36,324 $4.89 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $6.36 Million - $7.33 Million	-44,000 Reduced 51.5%	41,443 $6.6 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $31,811 - $38,150	-230 Reduced 0.27%	85,443 $13.8 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.44 Million - $1.65 Million	-10,735 Reduced 11.13%	85,673 $11.5 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.86 Million - $2.37 Million	-13,550 Reduced 12.32%	96,408 $14.8 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $3.27 Million - $4.06 Million	-24,800 Reduced 18.4%	109,958 $17.8 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $1.15 Million - $1.45 Million	-10,700 Reduced 7.36%	134,758 $18.2 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $693,728 - $787,485	-6,520 Reduced 4.29%	145,458 $15.7 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $3.6 Million - $4.01 Million	-34,200 Reduced 18.37%	151,978 $17.1 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $40,920 - $45,048	400 Added 0.22%	186,178 $20.1 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $8,048 - $10,867	-100 Reduced 0.05%	185,778 $19.9 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $1.22 Million - $1.43 Million	-14,230 Reduced 7.11%	185,878 $16.3 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $33,530 - $44,868	-457 Reduced 0.23%	200,108 $19.6 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $632,100 - $958,342	-9,800 Reduced 4.66%	200,565 $15.3 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $2.84 Million - $3.56 Million	39,430 Added 23.07%	210,365 $18.6 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $102,027 - $122,666	-1,620 Reduced 0.94%	170,935 $12.9 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $2.52 Million - $3.22 Million	38,400 Added 28.62%	172,555 $12.5 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $834,654 - $982,347	-10,820 Reduced 7.46%	134,155 $10.8 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $716,220 - $883,292	-9,200 Reduced 5.97%	144,975 $13.4 Million
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $3.87 Million - $4.3 Million	43,500 Added 39.3%	154,175 $14.6 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $107,736 - $127,476	-1,200 Reduced 1.07%	110,675 $10.3 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $1.34 Million - $1.79 Million	-14,550 Reduced 11.51%	111,875 $10.6 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $1.41 Million - $1.54 Million	-15,700 Reduced 11.05%	126,425 $12.2 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $9.93 Million - $12.7 Million	142,125	142,125 $12.6 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.

Account

Skba Capital Management LLC Abb Vie Inc. Transaction History